Compounds > ziprasidone
Page last updated: 2024-08-24

ziprasidone and Adverse Drug Event

ziprasidone has been researched along with Adverse Drug Event in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W1
Chen, QX; Huang, WQ; Liu, WZ; Wang, GF; Zhang, JJ1
Citrome, L1
Hussar, DA1
Anders, JL1
Domin, S; Kasper, S; Kudla, D; Lambert, M; Naber, D1

Reviews

1 review(s) available for ziprasidone and Adverse Drug Event

ArticleYear
Drug safety evaluation of ziprasidone.
    Expert opinion on drug safety, 2011, Volume: 10, Issue:3

    Topics: Antipsychotic Agents; Bipolar Disorder; Clinical Trials as Topic; Drug-Related Side Effects and Adverse Reactions; Humans; Long QT Syndrome; Piperazines; Schizophrenia; Thiazoles

2011

Trials

1 trial(s) available for ziprasidone and Adverse Drug Event

ArticleYear
[Pharmacokinetics and relative bioavailability of ziprasidone tablets in Chinese healthy volunteers].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2009, Volume: 29, Issue:8

    Topics: Administration, Oral; Asian People; Biological Availability; Drug-Related Side Effects and Adverse Reactions; Health; Humans; Piperazines; Tablets; Therapeutic Equivalency; Thiazoles; Time Factors; Young Adult

2009

Other Studies

4 other study(ies) available for ziprasidone and Adverse Drug Event

ArticleYear
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
    PLoS computational biology, 2011, Volume: 7, Issue:12

    Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests

2011
New drugs 2002, part 1.
    Nursing, 2002, Volume: 32, Issue:1

    Topics: Amides; Aminosalicylic Acids; Anti-Ulcer Agents; Antipsychotic Agents; Bimatoprost; Cloprostenol; Cyclohexanes; Drug Approval; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Galantamine; Glaucoma; Gonadotropin-Releasing Hormone; Humans; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Long-Acting; Lipids; Mesalamine; Nateglinide; Nootropic Agents; Phenylalanine; Phenylhydrazines; Piperazines; Thiazoles; Travoprost

2002
Applying parsimony to "An African patient with ziprasidone intolerance".
    The Journal of clinical psychiatry, 2005, Volume: 66, Issue:11

    Topics: Antipsychotic Agents; Anxiety Disorders; Black or African American; Culture; Depressive Disorder; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Pharmacogenetics; Piperazines; Polymorphism, Genetic; Thiazoles

2005
Effectiveness, tolerability, and safety of ziprasidone in patients with schizophrenia or schizoaffective disorder: results of a multi-centre observational trial.
    European psychiatry : the journal of the Association of European Psychiatrists, 2007, Volume: 22, Issue:3

    Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Austria; Blood Glucose; Body Weight; Brief Psychiatric Rating Scale; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Germany; Humans; Lipids; Male; Middle Aged; Patient Dropouts; Piperazines; Product Surveillance, Postmarketing; Prospective Studies; Psychotic Disorders; Quality of Life; Schizophrenia; Thiazoles; Treatment Outcome

2007